Keyphrases
Trypanosoma Cruzi (T. cruzi)
100%
Mannose
100%
Phosphomannomutase
100%
Pyrophosphatase
100%
Ligandability
100%
Guanosine Diphosphate
100%
GDP-mannose Pyrophosphorylase
83%
Chagas Disease
50%
Drug Discovery
33%
Cell Surface
33%
Glycoconjugates
33%
Nucleotide Sugars
33%
Chemical Space
33%
Deconvolution
16%
GPI-anchored Protein (GPI-AP)
16%
GDP-mannose
16%
Life Cycle Stages
16%
Drug-like
16%
Small Fragments
16%
Small Molecules
16%
Biosynthetic Pathway
16%
Retesting
16%
Therapeutic Target
16%
Global Health Issue
16%
New Therapeutic Agents
16%
Competitive Inhibitor
16%
Phospholipids
16%
Enzyme Forms
16%
Conventional Drugs
16%
Compound II
16%
Surface Architecture
16%
Dolichol
16%
Mucin Glycoprotein
16%
All Life Cycle
16%
Compound 3
16%
Uncompetitive Inhibitor
16%
Biochemistry, Genetics and Molecular Biology
Trypanosoma Cruzi
100%
Phosphomannomutase
100%
Guanosine Diphosphate Mannose
100%
Mannose
100%
Enzyme
75%
Glycoconjugate
25%
Nucleotide Sugar
25%
Small Molecule
12%
Glycosylphosphatidylinositol
12%
Anabolism
12%
Glycoprotein
12%
Competitive Inhibition
12%
Life Cycle Stage
12%
Mucin
12%
Dolichol
12%
Uncompetitive Inhibitor
12%
Phospholipid
12%
Pharmacology, Toxicology and Pharmaceutical Science
Trypanosoma Cruzi
100%
Mannose
100%
Phosphomannomutase
100%
Guanosine Diphosphate Mannose
100%
Chagas Disease
37%
Drug Discovery
25%
Sugar Nucleotide
25%
Glycoconjugate
25%
Disease
12%
Glycosylphosphatidylinositol
12%
Glycoprotein
12%
Competitive Inhibitor
12%
Phospholipid
12%
Life Cycle Stage
12%
Mucin
12%
Mannose Phosphate
12%
Dolichol
12%
Immunology and Microbiology
Chagas Disease
100%
Trypanosoma Cruzi
100%
Cell Surface
66%
Glycoconjugate
66%
Glycoprotein
33%
Life Cycle Stage
33%
Biosynthesis
33%
Mucin
33%
Competitive Inhibition
33%